Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]

A Single Technology Appraisal

Ed Griffin, Max Barnish, David Packman, Helen Coelho, Justin Matthews, Sophie Dodman, Sophie Robinson, Adam Dangoor, Nicole Dorey, Martin Hoyle

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherUniversity of Exeter
Commissioning bodyThe National Institute for Health and Care Excellence (NICE)
Number of pages189
Publication statusPublished - 2018
Externally publishedYes

Cite this

Griffin, E., Barnish, M., Packman, D., Coelho, H., Matthews, J., Dodman, S., ... Hoyle, M. (2018). Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]: A Single Technology Appraisal. University of Exeter.